1. Home
  2. APLS vs KN Comparison

APLS vs KN Comparison

Compare APLS & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • KN
  • Stock Information
  • Founded
  • APLS 2009
  • KN 1946
  • Country
  • APLS United States
  • KN United States
  • Employees
  • APLS N/A
  • KN N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • KN Consumer Electronics/Appliances
  • Sector
  • APLS Health Care
  • KN Consumer Staples
  • Exchange
  • APLS Nasdaq
  • KN Nasdaq
  • Market Cap
  • APLS 2.2B
  • KN 1.8B
  • IPO Year
  • APLS 2017
  • KN N/A
  • Fundamental
  • Price
  • APLS $16.93
  • KN $16.41
  • Analyst Decision
  • APLS Buy
  • KN Buy
  • Analyst Count
  • APLS 19
  • KN 2
  • Target Price
  • APLS $37.50
  • KN $20.50
  • AVG Volume (30 Days)
  • APLS 2.9M
  • KN 584.0K
  • Earning Date
  • APLS 05-07-2025
  • KN 07-30-2025
  • Dividend Yield
  • APLS N/A
  • KN N/A
  • EPS Growth
  • APLS N/A
  • KN N/A
  • EPS
  • APLS N/A
  • KN N/A
  • Revenue
  • APLS $775,839,000.00
  • KN $552,400,000.00
  • Revenue This Year
  • APLS $1.54
  • KN $6.49
  • Revenue Next Year
  • APLS $22.80
  • KN $5.68
  • P/E Ratio
  • APLS N/A
  • KN N/A
  • Revenue Growth
  • APLS 48.04
  • KN 23.91
  • 52 Week Low
  • APLS $16.10
  • KN $12.19
  • 52 Week High
  • APLS $43.76
  • KN $20.86
  • Technical
  • Relative Strength Index (RSI)
  • APLS 41.44
  • KN 51.50
  • Support Level
  • APLS $16.61
  • KN $16.09
  • Resistance Level
  • APLS $17.48
  • KN $16.71
  • Average True Range (ATR)
  • APLS 0.86
  • KN 0.32
  • MACD
  • APLS 0.09
  • KN -0.09
  • Stochastic Oscillator
  • APLS 28.47
  • KN 20.92

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.

Share on Social Networks: